PTC Therapeutics Inc (PTCT)
38.64
-0.21
(-0.54%)
USD |
NASDAQ |
May 22, 16:00
38.68
+0.04
(+0.10%)
After-Hours: 20:00
PTC Therapeutics Gross Profit (TTM): 861.48M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 861.48M |
December 31, 2023 | 872.34M |
September 30, 2023 | 750.92M |
June 30, 2023 | 766.95M |
March 31, 2023 | 721.76M |
December 31, 2022 | 654.12M |
September 30, 2022 | 653.50M |
June 30, 2022 | 582.59M |
March 31, 2022 | 536.02M |
December 31, 2021 | 506.26M |
September 30, 2021 | 464.34M |
June 30, 2021 | 445.87M |
March 31, 2021 | 406.49M |
December 31, 2020 | 361.82M |
September 30, 2020 | 340.76M |
Date | Value |
---|---|
June 30, 2020 | 295.44M |
March 31, 2020 | 307.81M |
December 31, 2019 | 294.84M |
September 30, 2019 | 284.50M |
June 30, 2019 | 266.39M |
March 31, 2019 | 250.25M |
December 31, 2018 | 252.06M |
September 30, 2018 | 245.08M |
June 30, 2018 | 235.05M |
March 31, 2018 | 216.09M |
December 31, 2017 | 189.58M |
September 30, 2017 | 139.17M |
June 30, 2017 | 121.89M |
March 31, 2017 | 90.32M |
December 31, 2016 | 82.70M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
266.39M
Minimum
Jun 2019
872.34M
Maximum
Dec 2023
518.71M
Average
485.30M
Median
Gross Profit (TTM) Benchmarks
Sarepta Therapeutics Inc | 1.237B |
Pfizer Inc | 31.64B |
Catalyst Pharmaceuticals Inc | 356.81M |
Regenxbio Inc | 49.34M |
Edgewise Therapeutics Inc | -- |